Search Within

Chaitanya Divgi

  1. "Surgery"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (7)
Groups
  1. Surgery (15)
  2. Molecular Pharmacology and Chemistry Program Faculty (13)
  3. Sloan Kettering Institute Faculty (13)
  4. GSK Faculty (12)
  5. Molecular Imaging and Therapy Service (12)
  6. Radiology, Department of (12)

More Groups

People
  1. Steven Larson (11)
  2. John Humm (6)
  3. Neeta Pandit-Taskar (6)
  4. Peter Smith-Jones (5)
  5. Connie Finstad (4)
  6. Kenneth Lloyd (4)

More People

Years
  1. 2011 (2)
  2. 2007 (2)
  3. 2005 (2)
  4. 2004 (1)
  5. 2003 (2)
  6. 2002 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (5)
  2. Journal of Clinical Oncology (3)
  3. Clinical Cancer Research (2)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  5. European Journal of Nuclear Medicine and Molecular Imaging (1)
  6. Gynecologic Oncology (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (5)
  2. American Association for Cancer Research (4)
  3. American Society of Clinical Oncology (3)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. Springer (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (124)I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Journal Article

    O'Donoghue, J. A.; Smith-Jones, P. M.; Humm, J. L.; Ruan, S.; Pryma, D. A.; Jungbluth, A. A.; Divgi, C. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Fong, Y.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • A phase II study of preoperative chemotherapy with irinotecan (CPT) and cisplatin (CIS) for gastric cancer (NCI 5917): FDG-PET/CT predicts patient outcome
    Meeting Abstract

    Shah, M. A.; Yeung, H.; Coit, D.; Trocola, R.; Ilson, D.; Randazzo, J.; Tang, L.; Brennan, M.; Divgi, C.; Kelsen, D. P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial
    Journal Article

    Divgi, C. R.; Pandit-Taskar, N.; Jungbluth, A. A.; Reuter, V. E.; Gonen, M.; Ruan, S.; Pierre, C.; Nagel, A.; Pryma, D. A.; Humm, J.; more...
    Lancet Oncology (2007)

    Fulltext@MSK | Save
  • Assessment of fetal radiation dose during maternal sentinel lymph node mapping for breast cancer
    Meeting Abstract

    Montgomery, L.; Dauer, L.; Doddamane, I.; St. Germain, J.; Zanzonico, P.; Cody, H.; Borgen, P.; Divgi, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
    Journal Article

    Morris, M. J.; Divgi, C. R.; Pandit-Taskar, N.; Batraki, M.; Warren, N.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Lymphoscintigraphy in cervical cancer
    Meeting Abstract

    Pandit-Taskar, N.; Gemignani, M. L.; Reyes, S.; Barakat, R. R.; Divgi, C. R.
    European Journal of Nuclear Medicine and Molecular Imaging (2004)

    Fulltext@MSK | Save
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Optimization of biodistribution parameters for radioimmunotherapy: Clinical trial with HuJ591
    Meeting Abstract

    Pandit-Taskar, N.; Morris, M. J.; Batraki, M.; Perez, A.; Nacca, A.; Smith-Jones, P.; Halpern, J.; Finn, R.; Scher, H. I.; Bander, N. H.; more...
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
    Journal Article

    Robbins, R. J.; Larson, S. M.; Sinha, N.; Shaha, A.; Divgi, C.; Pentlow, K. S.; Ghossein, R.; Tuttle, R. M.
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save